Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Study links missing brain protein to ADHD-like behaviors (opens in a new tab)

news-medical.net · 2026-09-16

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 2 supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Two of four claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

  • 2 supported
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredThe modified mice showed ADHD-like behaviors, including greater hyperactivity and more impulsive-like jumping behavior than control mice.View evidenceHide evidence

As stated86% of the experimental group vs 31% of controls jumped by the end of the seven-minute test

Why this verdict

The abstract supports the general claim that Nsf f/f;D2R-Cre mice exhibited ADHD-like behaviors, including hyperactivity and impulsivity, relative to controls. However, the supplied abstract-level profile does not provide the specific jumping assay, the seven-minute test, or the stated 86% vs 31% magnitude, so the claim as quantified cannot be verified at this depth.

1

Study evidence

Nsf f/f;D2R-Cre mice displayed ADHD-like behaviors, specifically increased hyperactivity and impulsivity, relative to controls.

“Nsf f/f;D2R-Cre mice exhibited attention-deficit/hyperactivity disorder (ADHD)-like behaviors, including hyperactivity and impulsivity.”
Claim 2 of 4Not coveredMethylphenidate alone did not significantly reduce hyperactivity in the knockout mice, but methylphenidate combined with quinpirole reduced hyperactivity and impulsive-like behavior.View evidenceHide evidence

As statedjumping fell from 78% without treatment to 11% after the two drugs were given together

Why this verdict

The abstract supports that combined methylphenidate plus quinpirole alleviated hyperactivity and impulsivity in the knockout mice. But it does not report whether methylphenidate alone was tested or failed significantly, nor does it provide the stated jumping reduction from 78% to 11%, dosing, timing, or statistical details. Those parts are not verifiable from the abstract-level profile.

1

Study evidence

Combined methylphenidate + quinpirole treatment alleviated hyperactivity and impulsivity in Nsf f/f;D2R-Cre mice (as reported in abstract).

“Combined administration of methylphenidate and a D2R agonist, quinpirole, alleviated both behaviors”
2

Study evidence

Nsf f/f;D2R-Cre mice displayed ADHD-like behaviors, specifically increased hyperactivity and impulsivity, relative to controls.

“Nsf f/f;D2R-Cre mice exhibited attention-deficit/hyperactivity disorder (ADHD)-like behaviors, including hyperactivity and impulsivity.”
Claim 3 of 4SupportedA research team from Japan investigated the role of N-ethylmaleimide-sensitive factor (NSF) in dopamine D2 receptor-expressing brain cells because of a suspected link to ADHD-related dopaminergic dysfunction.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the study tested NSF deletion in D2R-expressing cells in vivo and links NSF/D2R biology to dopaminergic function and ADHD-like phenotypes. The specific affiliation/location detail is not evidenced in the supplied profile, but the scientific framing of the hypothesis is supported.

1

Study evidence

D2R-specific NSF conditional knockout mice (Nsf f/f;D2R-Cre) were generated.

“We generated D2R-specific NSF conditional knockout (Nsf f/f;D2R-Cre) mice.”
2

Study evidence

Striatal dopamine levels were markedly lower in Nsf f/f;D2R-Cre mice.markedly lower

“markedly lower striatal dopamine levels.”
Claim 4 of 4SupportedIn knockout mice lacking NSF specifically in D2R-expressing cells, the loss of NSF reduced the number of those cells, increased early developmental cell death, shrank the striatum, and lowered dopamine levels in that brain region.View evidenceHide evidence

Why this verdict

The abstract reports targeted NSF deletion in D2R-expressing cells reduced D2R expression and D2R-expressing cell density, was accompanied by increased early postnatal apoptotic cell death and reduced striatal volume, and produced markedly lower striatal dopamine levels. In a conditional knockout mouse model, the story’s causal framing is consistent with the paper profile.

1

Study evidence

D2R-specific NSF conditional knockout mice (Nsf f/f;D2R-Cre) were generated.

“We generated D2R-specific NSF conditional knockout (Nsf f/f;D2R-Cre) mice.”
2

Study evidence

Striatal dopamine levels were markedly lower in Nsf f/f;D2R-Cre mice.markedly lower

“markedly lower striatal dopamine levels.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The paper also reports reduced dopaminergic markers: dopamine transporter expression in striatum and tyrosine hydroxylase expression in striatum and substantia nigra.

    The story mentions lower dopamine but does not mention the DAT or TH marker reductions described in the abstract-level profile.

    From in_vivo_animal

5 things the story did carry across
  • The paper’s central model is a D2R-specific NSF conditional knockout mouse, used to test NSF’s role in D2R-expressing cells in vivo.
  • Targeted NSF deletion reduced D2R expression/D2R-expressing cell density, increased early postnatal apoptosis, reduced striatal volume, and lowered striatal dopamine levels.
  • The knockout mice showed ADHD-like behavioral phenotypes, including hyperactivity and impulsivity.
  • Combined methylphenidate plus the D2R agonist quinpirole alleviated hyperactivity and impulsivity in knockout mice.
  • The work is basic in vivo animal research and should not be treated as an established human ADHD therapy.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

4

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalDetermine how conditional deletion of NSF in dopamine D2 receptor (D2R)-expressing cells affects striatal development, D2R-associated cell populations/markers, and dopaminergic function in vivo.conditional gene knockout (D2R-Cre)Expand

In plain English

The study generated D2R-specific N-ethylmaleimide-sensitive factor (NSF) conditional knockout mice (Nsf f/f;D2R-Cre) and found that targeted NSF deletion in D2R-expressing cells reduced D2R expression and the density of D2R-expressing neurons (and the associated marker preproenkephalin), increased apoptotic cell death during early postnatal development, and led to reduced striatal volume and markedly lower striatal dopamine levels, together with reduced dopamine transporter and tyrosine hydroxylase expression in striatum and substantia nigra.

Key findings

  • D2R-specific NSF conditional knockout mice (Nsf f/f;D2R-Cre) were generated.
  • Targeted NSF deletion reduced D2R expression and the density of D2R-expressing cells, and reduced the associated marker preproenkephalin.
“We generated D2R-specific NSF conditional knockout (Nsf f/f;D2R-Cre) mice.”
What this piece can’t prove

2 further details could not be confirmed from the summary.

2in vivo animalDetermine how conditional deletion of NSF in dopamine D2 receptor (D2R)-expressing cells affects striatal development, D2R-associated cell populations/markers, and dopaminergic function in vivo.in vivo animalExpand

In plain English

In Nsf f/f;D2R-Cre conditional knockout mice (NSF deleted in D2R-expressing cells), striatal dopaminergic neurotransmission was impaired: striatal dopamine content was reported as markedly lower, and dopaminergic marker expression was reduced (decreased dopamine transporter in striatum and decreased tyrosine hydroxylase in striatum and substantia nigra). These neurochemical and marker changes were presented as evidence of dopaminergic impairment in this model.

Key findings

  • Striatal dopamine levels were markedly lower in Nsf f/f;D2R-Cre mice.markedly lower
  • Dopamine transporter (DAT) expression was reduced in the striatum of Nsf f/f;D2R-Cre mice.reduced
“markedly lower striatal dopamine levels.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

3in vivo animalTest whether D2R-specific NSF conditional knockout mice exhibit ADHD-like behaviors and whether pharmacologic treatment (methylphenidate plus D2R agonist quinpirole) rescues behavioral phenotypes.in vivo animal behavioral testing (KO vs control, pharmacologic intervention)Expand

In plain English

In D2R-specific NSF conditional knockout (Nsf f/f;D2R-Cre) mice, the authors report ADHD-like behaviors (hyperactivity and impulsivity) relative to controls; combined administration of methylphenidate and the D2R agonist quinpirole reportedly alleviated these behavioral phenotypes.

Key findings

  • Nsf f/f;D2R-Cre mice displayed ADHD-like behaviors, specifically increased hyperactivity and impulsivity, relative to controls.
  • Combined administration of methylphenidate and the D2R agonist quinpirole reportedly alleviated both hyperactivity and impulsivity in knockout mice.
“Nsf f/f;D2R-Cre mice exhibited attention-deficit/hyperactivity disorder (ADHD)-like behaviors, including hyperactivity and impulsivity.”
What this piece can’t prove
  • Pharmacologic rescue details (dosing, controls, single-agent comparisons) are not specified, limiting interpretation of specificity and translational applicability.

2 further details could not be confirmed from the summary.

4in vivo animalTest whether D2R-specific NSF conditional knockout mice exhibit ADHD-like behaviors and whether pharmacologic treatment (methylphenidate plus D2R agonist quinpirole) rescues behavioral phenotypes.in vivo pharmacologic intervention (combined methylphenidate + quinpirole vs control)Expand

In plain English

In Nsf f/f;D2R-Cre mice (D2R-specific NSF conditional knockouts) the abstract reports that combined administration of methylphenidate and the D2R agonist quinpirole alleviated ADHD-like behaviors—specifically hyperactivity and impulsivity.

Key findings

  • Combined methylphenidate + quinpirole treatment alleviated hyperactivity and impulsivity in Nsf f/f;D2R-Cre mice (as reported in abstract).
“Combined administration of methylphenidate and a D2R agonist, quinpirole, alleviated both behaviors”
What this piece can’t prove
  • Unclear whether single-drug controls were included or whether the observed rescue is additive/synergistic or driven primarily by one agent.
  • Unspecified whether behavioral assessments were blinded and how generalizable the acute/short-term rescue is to longer-term outcomes.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Deletion of N-ethylmaleimide-sensitive factor in dopamine D2 receptor-expressing cells impairs striatal development and dopaminergic function and induces ADHD-like behaviors in mice

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026

Deep dive in Tessa (opens in a new tab)Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 34 candidate papers

Selected

Deletion of N-ethylmaleimide-sensitive factor in dopamine D2 receptor-expressing cells impairs striatal development and dopaminergic function and induces ADHD-like behaviors in mice

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology · 2026 · PubMed, Europe PMC, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

Author response for "From Prompt Engineering to Modeling: Secondary Science Teachers’ Use of Generative AI to Engineer Sweetener Molecules"

2026 · Crossref

Source (opens in a new tab)

And 28 more candidates considered.